{"id":"https://openalex.org/W2112974875","doi":"https://doi.org/10.1016/j.bbmt.2010.09.013","title":"Syngeneic Donor Hematopoietic Stem Cell Transplantation Is Associated with High Rates of Engraftment Syndrome","display_name":"Syngeneic Donor Hematopoietic Stem Cell Transplantation Is Associated with High Rates of Engraftment Syndrome","publication_year":2010,"publication_date":"2010-09-25","ids":{"openalex":"https://openalex.org/W2112974875","doi":"https://doi.org/10.1016/j.bbmt.2010.09.013","mag":"2112974875","pmid":"https://pubmed.ncbi.nlm.nih.gov/20870027"},"language":"en","primary_location":{"id":"doi:10.1016/j.bbmt.2010.09.013","doi":"https://doi.org/10.1016/j.bbmt.2010.09.013","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2010.09.013","pdf_url":"http://www.astctjournal.org/article/S1083879110003939/pdf","source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.astctjournal.org/article/S1083879110003939/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029390145","display_name":"John Koreth","orcid":"https://orcid.org/0000-0002-7428-1330","observed_orcids":["https://orcid.org/0000-0002-7428-1330"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John Koreth","raw_affiliation_strings":["Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. john_koreth@dfci.harvard.edu","Division of Hematologic Malignancies; Dana-Farber Cancer Institute; Boston Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. john_koreth@dfci.harvard.edu","institution_ids":["https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Division of Hematologic Malignancies; Dana-Farber Cancer Institute; Boston Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041324758","display_name":"Melinda Ann Biernacki","orcid":"https://orcid.org/0000-0002-9527-0905","observed_orcids":["https://orcid.org/0000-0002-9527-0905"]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melinda Biernacki","raw_affiliation_strings":["Department of Medicine, Brown University, Providence, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Brown University, Providence, Rhode Island","institution_ids":["https://openalex.org/I27804330"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029218146","display_name":"Julie Aldridge","orcid":"https://orcid.org/0000-0001-6724-7591","observed_orcids":["https://orcid.org/0000-0001-6724-7591"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Aldridge","raw_affiliation_strings":["Department of Biostatistics & Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts","Department of Biostatistics and Computational Biology Dana Farber Cancer Institute Boston Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics & Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Biostatistics and Computational Biology Dana Farber Cancer Institute Boston Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045479163","display_name":"Haesook T. Kim","orcid":"https://orcid.org/0000-0003-4889-6849","observed_orcids":["https://orcid.org/0000-0003-4889-6849"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haesook T. Kim","raw_affiliation_strings":["Department of Biostatistics & Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts","Department of Biostatistics and Computational Biology Dana Farber Cancer Institute Boston Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics & Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Biostatistics and Computational Biology Dana Farber Cancer Institute Boston Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074589634","display_name":"Edwin Pascal Alyea","orcid":"https://orcid.org/0000-0002-1885-8430","observed_orcids":["https://orcid.org/0000-0002-1885-8430"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edwin P. Alyea","raw_affiliation_strings":["Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053410437","display_name":"Philippe A. Armand","orcid":"https://orcid.org/0000-0001-6098-1603","observed_orcids":["https://orcid.org/0000-0001-6098-1603"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philippe Armand","raw_affiliation_strings":["Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029278364","display_name":"Corey S. Cutler","orcid":"https://orcid.org/0000-0001-8728-4314","observed_orcids":["https://orcid.org/0000-0001-8728-4314"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corey Cutler","raw_affiliation_strings":["Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031812464","display_name":"Vincent T. Ho","orcid":"https://orcid.org/0000-0001-6839-3996","observed_orcids":["https://orcid.org/0000-0001-6839-3996"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vincent T. Ho","raw_affiliation_strings":["Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047701430","display_name":"Catherine J. Wu","orcid":"https://orcid.org/0000-0002-3348-5054","observed_orcids":["https://orcid.org/0000-0002-3348-5054"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine J. Wu","raw_affiliation_strings":["Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054037976","display_name":"Joseph H. Antin","orcid":"https://orcid.org/0000-0003-4627-1714","observed_orcids":["https://orcid.org/0000-0003-4627-1714"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph H. Antin","raw_affiliation_strings":["Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068050082","display_name":"Robert J. Soiffer","orcid":"https://orcid.org/0000-0002-5810-1192","observed_orcids":["https://orcid.org/0000-0002-5810-1192"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Soiffer","raw_affiliation_strings":["Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5029390145"],"corresponding_institution_ids":["https://openalex.org/I4210117453","https://openalex.org/I4210134579"],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":0.4006,"has_fulltext":true,"cited_by_count":22,"citation_normalized_percentile":{"value":0.68860011,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"17","issue":"3","first_page":"421","last_page":"428"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/engraftment-syndrome","display_name":"engraftment syndrome","score":0.9940000176429749},{"id":"https://openalex.org/keywords/non-infectious-fever","display_name":"non-infectious fever","score":0.7319999933242798},{"id":"https://openalex.org/keywords/non-cardiogenic-pulmonary-edema","display_name":"non-cardiogenic pulmonary edema","score":0.9459999799728394},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.8180000185966492},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.8489999771118164},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.5509999990463257},{"id":"https://openalex.org/keywords/total-body-irradiation-conditioning","display_name":"total body irradiation conditioning","score":0.875},{"id":"https://openalex.org/keywords/myeloid-neoplasms","display_name":"myeloid neoplasms","score":0.753000020980835},{"id":"https://openalex.org/keywords/lymphoid-malignancies","display_name":"lymphoid malignancies","score":0.7950000166893005},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.703000009059906},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.921999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9526954293251038},{"id":"https://openalex.org/C88879693","wikidata":"https://www.wikidata.org/wiki/Q217690","display_name":"Cumulative incidence","level":3,"score":0.8531422019004822},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.6620835065841675},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.6255285739898682},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.619315505027771},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.6098343729972839},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5395521521568298},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.5149610638618469},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.453289270401001},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4380427598953247},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.435837984085083},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.43180903792381287},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000375","descriptor_name":"Aging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004890","descriptor_name":"Erythema","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D004890","descriptor_name":"Erythema","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011654","descriptor_name":"Pulmonary Edema","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D011654","descriptor_name":"Pulmonary Edema","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013577","descriptor_name":"Syndrome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014185","descriptor_name":"Transplantation, Isogeneic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bbmt.2010.09.013","doi":"https://doi.org/10.1016/j.bbmt.2010.09.013","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2010.09.013","pdf_url":"http://www.astctjournal.org/article/S1083879110003939/pdf","source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},{"id":"pmid:20870027","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20870027","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.bbmt.2010.09.013","doi":"https://doi.org/10.1016/j.bbmt.2010.09.013","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2010.09.013","pdf_url":"http://www.astctjournal.org/article/S1083879110003939/pdf","source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2112974875.pdf","grobid_xml":"https://content.openalex.org/works/W2112974875.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1578235202","https://openalex.org/W1682288267","https://openalex.org/W1963976884","https://openalex.org/W1978418906","https://openalex.org/W1982154014","https://openalex.org/W2017773053","https://openalex.org/W2021624792","https://openalex.org/W2025908314","https://openalex.org/W2038981426","https://openalex.org/W2059192370","https://openalex.org/W2072639106","https://openalex.org/W2073140442","https://openalex.org/W2074157250","https://openalex.org/W2074425311","https://openalex.org/W2124433362","https://openalex.org/W2128812336","https://openalex.org/W2155153085","https://openalex.org/W2321053053","https://openalex.org/W2471208626"],"related_works":["https://openalex.org/W4245103048","https://openalex.org/W2009568945","https://openalex.org/W2075388288","https://openalex.org/W4307199223","https://openalex.org/W2025908314","https://openalex.org/W2947288948","https://openalex.org/W4311189979","https://openalex.org/W1502793109","https://openalex.org/W2604839852","https://openalex.org/W2981081582"],"abstract_inverted_index":{"Engraftment":[0],"syndrome":[1],"(ES),":[2],"typically":[3],"characterized":[4],"by":[5],"noninfectious":[6],"fever,":[7],"rash,":[8],"and/or":[9],"noncardiogenic":[10],"pulmonary":[11],"edema,":[12],"is":[13],"a":[14,53,246,264],"complication":[15],"of":[16,56,87,114,129,147,183,198,249,256],"autologous":[17],"and":[18,40,46,70,100,107,116,122,204,215,240],"allogeneic":[19],"hematopoietic":[20],"stem":[21],"cell":[22],"transplantation":[23],"(HSCT).":[24],"There":[25],"are":[26],"no":[27],"data":[28],"on":[29],"ES":[30,42,159,173,188,203,250,260],"after":[31,251,259],"syngeneic":[32,37,62,252,266],"HSCT.":[33,253],"We":[34],"retrospectively":[35],"analyzed":[36],"HSCT":[38,63,267],"outcomes":[39],"determined":[41],"incidence,":[43],"risk":[44,225],"factors,":[45],"prognostic":[47],"impact.":[48],"Thirty-two":[49],"adult":[50],"patients":[51,138,157],"with":[52,125,158,172,187,202],"median":[54,85],"age":[55,211],"46":[57],"years":[58,91],"(range:":[59,92],"22-60)":[60],"underwent":[61],"at":[64],"our":[65],"institution":[66],"between":[67],"July":[68],"1986":[69],"April":[71],"2009,":[72],"primarily":[73],"for":[74,143,227],"hematologic":[75],"malignancies":[76],"(65%":[77],"lymphoid-including":[78],"15%":[79],"plasma":[80],"cell;":[81],"31%":[82],"myeloid).":[83],"The":[84,254],"duration":[86],"follow-up":[88],"was":[89,105,120,154,170,185,200],"6.1":[90],"3.7":[93],"months":[94],"to":[95],"18.1":[96],"years).":[97],"Five-year":[98,110,152,168,180,195],"progression-free":[99],"overall":[101,111],"survival":[102],"(PFS,":[103],"OS)":[104],"52%":[106],"67%,":[108],"respectively.":[109],"cumulative":[112,181,196],"incidence":[113,128,182,197,248],"relapse":[115,127,199],"nonrelapse":[117],"mortality":[118],"(NRM)":[119],"37.6%":[121],"10.2%,":[123],"respectively;":[124],"increased":[126,257],"76.3%":[130],"in":[131,156,162,263],"myeloid":[132],"disease":[133],"(P":[134,165,177,192,207,212,221],"=":[135,166,178,193,208,213,222],".002).":[136],"Fifteen":[137],"(47%)":[139],"met":[140],"diagnostic":[141],"criteria":[142],"ES,":[144],"10":[145],"(67%)":[146],"whom":[148],"received":[149],"systemic":[150],"steroids.":[151],"PFS":[153],"47%":[155],"versus":[160,174,189],"56%":[161],"those":[163],"without":[164,176,191,206],".37).":[167],"OS":[169,239],"63%":[171],"71%":[175],".80).":[179],"NRM":[184,258],"21%":[186],"0%":[190],".06).":[194],"32%":[201],"44%":[205],".68).":[209],"Older":[210],".05)":[214],"possibly":[216],"total":[217],"body":[218],"irradiation-based":[219],"conditioning":[220],".09)":[223],"were":[224],"factors":[226],"developing":[228],"ES.":[229],"In":[230,242],"multivariable":[231],"Cox":[232],"models":[233],"only":[234],"diagnosis":[235],"(myeloid":[236],"disease)":[237],"impaired":[238],"PFS.":[241],"summary,":[243],"we":[244],"document":[245],"high":[247],"trend":[255],"requires":[261],"reevaluation":[262],"larger":[265],"cohort.":[268]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}